...
bglc-img

BioNexus Gene Lab Corp Common stock, Common Stock

BGLC

NAQ

$0.2601

-$0.01

(-3.69%)

1D
Industry: Chemicals Sector: Materials

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$5.21M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
39.70K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.87
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.23 L
$1.57 H
$0.2601

About BioNexus Gene Lab Corp Common stock, Common Stock

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia. more

Industry: ChemicalsSector: Materials

Returns

Time FrameBGLCSectorS&P500
1-Week Return-10.62%-2.08%-0.57%
1-Month Return-19.47%-2.89%1.21%
3-Month Return-34.98%-2.9%7.57%
6-Month Return-45.7%0.21%11.45%
1-Year Return-61.64%7.14%28.48%
3-Year Return-98.86%2.54%29.52%
5-Year Return-94.71%48.91%90.66%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue126.95K11.39M13.36M10.93M9.77M[{"date":"2019-12-31","value":0.95,"profit":true},{"date":"2020-12-31","value":85.24,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":81.79,"profit":true},{"date":"2023-12-31","value":73.12,"profit":true}]
Cost of Revenue71.07K9.67M11.17M9.67M8.44M[{"date":"2019-12-31","value":0.64,"profit":true},{"date":"2020-12-31","value":86.59,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":86.58,"profit":true},{"date":"2023-12-31","value":75.58,"profit":true}]
Gross Profit55.89K1.72M2.19M1.26M1.33M[{"date":"2019-12-31","value":2.55,"profit":true},{"date":"2020-12-31","value":78.39,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":57.39,"profit":true},{"date":"2023-12-31","value":60.6,"profit":true}]
Gross Margin44.02%15.10%16.42%11.52%13.61%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":34.3,"profit":true},{"date":"2021-12-31","value":37.29,"profit":true},{"date":"2022-12-31","value":26.17,"profit":true},{"date":"2023-12-31","value":30.91,"profit":true}]
Operating Expenses331.59K446.00K1.14M1.55M3.92M[{"date":"2019-12-31","value":8.45,"profit":true},{"date":"2020-12-31","value":11.37,"profit":true},{"date":"2021-12-31","value":29.01,"profit":true},{"date":"2022-12-31","value":39.51,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(275.70K)1.27M1.06M(291.18K)(2.59M)[{"date":"2019-12-31","value":-21.64,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":82.89,"profit":true},{"date":"2022-12-31","value":-22.86,"profit":false},{"date":"2023-12-31","value":-203.61,"profit":false}]
Total Non-Operating Income/Expense-(22.63K)(25.95K)(24.96K)(28.44K)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-2262600,"profit":false},{"date":"2021-12-31","value":-2594600,"profit":false},{"date":"2022-12-31","value":-2495800,"profit":false},{"date":"2023-12-31","value":-2843700,"profit":false}]
Pre-Tax Income(275.70K)1.26M1.04M(303.66K)(2.61M)[{"date":"2019-12-31","value":-21.84,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":82.6,"profit":true},{"date":"2022-12-31","value":-24.05,"profit":false},{"date":"2023-12-31","value":-206.53,"profit":false}]
Income Taxes(29.24K)168.41K291.28K52.31K21.53K[{"date":"2019-12-31","value":-10.04,"profit":false},{"date":"2020-12-31","value":57.82,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":17.96,"profit":true},{"date":"2023-12-31","value":7.39,"profit":true}]
Income After Taxes-1.09M751.57K(355.97K)(2.63M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":68.69,"profit":true},{"date":"2022-12-31","value":-32.54,"profit":false},{"date":"2023-12-31","value":-240.29,"profit":false}]
Income From Continuous Operations(246.47K)1.42M795.14K(355.97K)(3.09M)[{"date":"2019-12-31","value":-17.32,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":55.86,"profit":true},{"date":"2022-12-31","value":-25.01,"profit":false},{"date":"2023-12-31","value":-217.33,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(246.47K)1.09M751.57K(355.97K)(2.63M)[{"date":"2019-12-31","value":-22.53,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":68.69,"profit":true},{"date":"2022-12-31","value":-32.54,"profit":false},{"date":"2023-12-31","value":-240.29,"profit":false}]
EPS (Diluted)0.010.020.03(0.02)(0.16)[{"date":"2019-12-31","value":28.72,"profit":true},{"date":"2020-12-31","value":56.4,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-85.12,"profit":false},{"date":"2023-12-31","value":-556.06,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

BGLC
Cash Ratio 2.92
Current Ratio 4.98
Quick Ratio 3.99

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BGLC
ROA (LTM) -10.11%
ROE (LTM) -28.44%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BGLC
Debt Ratio Lower is generally better. Negative is bad. 0.15
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.85

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BGLC
Trailing PE NM
Forward PE NM
P/S (TTM) 0.51
P/B 0.50
Price/FCF NM
EV/R 0.08
EV/Ebitda 629.53

FAQs

What is BioNexus Gene Lab Corp Common stock share price today?

BioNexus Gene Lab Corp Common stock (BGLC) share price today is $0.2601

Can Indians buy BioNexus Gene Lab Corp Common stock shares?

Yes, Indians can buy shares of BioNexus Gene Lab Corp Common stock (BGLC) on Vested. To buy BioNexus Gene Lab Corp Common stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BGLC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of BioNexus Gene Lab Corp Common stock be purchased?

Yes, you can purchase fractional shares of BioNexus Gene Lab Corp Common stock (BGLC) via the Vested app. You can start investing in BioNexus Gene Lab Corp Common stock (BGLC) with a minimum investment of $1.

How to invest in BioNexus Gene Lab Corp Common stock shares from India?

You can invest in shares of BioNexus Gene Lab Corp Common stock (BGLC) via Vested in three simple steps:

  • Click on Sign Up or Invest in BGLC stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in BioNexus Gene Lab Corp Common stock shares
What is BioNexus Gene Lab Corp Common stock 52-week high and low stock price?

The 52-week high price of BioNexus Gene Lab Corp Common stock (BGLC) is $1.57. The 52-week low price of BioNexus Gene Lab Corp Common stock (BGLC) is $0.23.

What is BioNexus Gene Lab Corp Common stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of BioNexus Gene Lab Corp Common stock (BGLC) is

What is BioNexus Gene Lab Corp Common stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of BioNexus Gene Lab Corp Common stock (BGLC) is 0.50

What is BioNexus Gene Lab Corp Common stock dividend yield?

The dividend yield of BioNexus Gene Lab Corp Common stock (BGLC) is 0.00%

What is the Market Cap of BioNexus Gene Lab Corp Common stock?

The market capitalization of BioNexus Gene Lab Corp Common stock (BGLC) is $5.21M

What is BioNexus Gene Lab Corp Common stock’s stock symbol?

The stock symbol (or ticker) of BioNexus Gene Lab Corp Common stock is BGLC

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top